Skip to content

Effect of Bee Food Supplement Propolis on Food intake, Severity of disease and Quality of life in Patients with Irritable Bowel Syndrome (based on RomeIV criteria): a Randomized Double-Blind Clinical Trial

Effect of Bee Food Supplement Propolis on Food intake, Severity of disease and Quality of life in Patients with Irritable Bowel Syndrome (based on RomeIV criteria): a Randomized Double-Blind Clinical Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190708044154N1
Enrollment
52
Registered
2019-12-26
Start date
2019-07-31
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: Propolis extract at a dose of 500 mg per day for six weeks, taking 2 tablets daily. Intervention 2: Control group: Placebo at a dose of 500 mg per day for six conse

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients diagnose irritable bowel syndrome with Rome IV criteria Filling out the written consent form Not having allergy to bee products

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Cases of malignancy or other chronic digestive diseases such as inflammatory bowel disease and celiac disease Regular use of drugs that modify gastrointestinal movements such as metoclopramide, cisapride, narcotics, diphenoxylate, etc. Regular use of laxatives History of major surgery in the digestive system (including Billroth's operating, having any Ostomy and resection of any part of the digestive tract). Following diet plans Individuals with daily and regular use of Prebiotic/ probiotic compounds Consumption antibiotics People who use psychotherapeutic drugs, including depression and anxiety.

Design outcomes

Primary

MeasureTime frame
Severity of Irritable bowel syndrome. Timepoint: At the beginning of the study and the sixth week of the intervention. Method of measurement: IBS Severity Index(IBSSI).

Secondary

MeasureTime frame
Quality of life in Patients with Irritable Bowel Syndrome. Timepoint: At the beginning of the study and the sixth week of the intervention. Method of measurement: Irritable Bowel Syndrome Quality of Life questionnaire (IBS-QOL).;Food intake in Patients with Irritable Bowel Syndrome. Timepoint: At the beginning of the study and the sixth week of the intervention. Method of measurement: 3-Day Food Intake Record.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Miryan

Tabriz University of Medical Sciences

miryanm2014@gmail.com+98 937 608 4602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 17, 2026